Renaissance
Renaissance IM Small Cap Growth
Small-cap Growth
Jun 2025 → Jun 2026
Our archive holds 2 letters from this strategy, behind 2 investment theses and positions in 7 companies. Every quote below is copied verbatim from the letter it came from.
2 letters in 2 years — follow all of Renaissance for every strategy.
What it bought and sold
Information Technology 17.6% 0.0% Commvault Systems, Zeta Global (BlackLine, Credo Technology)
Health Care 20.1% -4.2% BrightSpring Health Services (ADMA Biologics, Catalyst Pharmaceuticals, GeneDx)
BrightSpring Health Services (BTSG) was added during the quarter.
We exited our position in Catalyst Pharmaceuticals (CPRX) as the company agreed to be acquired by Angelini Pharma in an all-cash transaction.
However, Credo’s market capitalization has exceeded the upper threshold of our portfolio, therefore we exited our position at the end of the quarter.
Also held
- Commvault Systems
- TransMedics Group
- Zeta Global
Its investment theses
- BrightSpring Health ServicesJun 2026BrightSpring Health Services has a specialty pharmacy platform focused on oncology therapies, and its moat plus generic conversion opportunities should drive years of growth.
- ADMA BiologicsJun 2025ADMA Biologics is a commercial-stage biopharma company focused on plasma-based biologics for immune deficiencies and infectious disease prevention, with strong growth prospects and a target of $1 billion in revenue by 2030.